Chapter 13. Management of Venous Thromboembolism in Pregnancy

  1. Mark A. Crowther MD, MSc, FRCPC Professor Division Director3,4,
  2. Jeff Ginsberg MD, FRCPC Professor5,
  3. Holger J. Schünemann MD, PhD, MSc, FACP, FCCP Professor6,7,
  4. Ralph M. Meyer MD, FRCPC Director Professor8,9 and
  5. Richard Lottenberg MD, FACP Professor10
  1. Wee-Shian Chan MD, FRCPC, MSc1,2

Published Online: 4 FEB 2009

DOI: 10.1002/9781444300857.ch13

Evidence-Based Hematology

Evidence-Based Hematology

How to Cite

Chan, W.-S. (2008) Management of Venous Thromboembolism in Pregnancy, in Evidence-Based Hematology (eds M. A. Crowther, J. Ginsberg, H. J. Schünemann, R. M. Meyer and R. Lottenberg), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444300857.ch13

Editor Information

  1. 3

    Division of Hematology, McMaster University, Hamilton, Ontario, Canada

  2. 4

    St. Joseph's Hospital, Hamilton, Ontario, Canada

  3. 5

    Department of Medicine, McMaster University, Hamilton, Canada

  4. 6

    CLARITY Research Group, Department of Epidemiology, Italian National Cancer Institute Regina Elena, Rome, Italy

  5. 7

    McMaster University, Hamilton, Canada

  6. 8

    National Cancer Institute of Canada, Clinical Trials Group, Edith Eisenhauer Chair in Clinical Cancer Research, Queen's University, Kingston, Ontario, Canada

  7. 9

    Departments of Oncology and Medicine, Queen's University, Kingston, Ontario, Canada

  8. 10

    Division of Hematology/Oncology, Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA

Author Information

  1. 1

    Department of Medicine, Women's College Hospital, Ontario, Canada

  2. 2

    Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Publication History

  1. Published Online: 4 FEB 2009
  2. Published Print: 27 JUN 2008

ISBN Information

Print ISBN: 9781405157476

Online ISBN: 9781444300857



  • venous thromboembolism (VTE) in pregnancy;
  • management of VTE in pregnancy;
  • diagnosing pulmonary embolism (PE) in pregnancy;
  • treating VTE in pregnancy;
  • LMWH dose administered - patient's weight;
  • managing pregnant women with prosthetic heart valves;
  • thromboprophylaxis;
  • length of treatment with therapeutic LMWH during pregnancy for active VTE - unknown


This chapter contains sections titled:

  • Introduction

  • References